Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.

<h4>Background</h4>The objective of this retrospective study was to determine whether lymph node metastasis has a prognostic impact on patients with stage IV breast cancer.<h4>Patients and methods</h4>Seven thousand three hundred and seventy-nine patients with de novo stage I...

Full description

Saved in:
Bibliographic Details
Main Authors: Chuangang Tang, Pei Wang, Xiaoxin Li, Bingqing Zhao, Haochang Yang, Haifeng Yu, Changwen Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182953&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850076471266115584
author Chuangang Tang
Pei Wang
Xiaoxin Li
Bingqing Zhao
Haochang Yang
Haifeng Yu
Changwen Li
author_facet Chuangang Tang
Pei Wang
Xiaoxin Li
Bingqing Zhao
Haochang Yang
Haifeng Yu
Changwen Li
author_sort Chuangang Tang
collection DOAJ
description <h4>Background</h4>The objective of this retrospective study was to determine whether lymph node metastasis has a prognostic impact on patients with stage IV breast cancer.<h4>Patients and methods</h4>Seven thousand three hundred and seventy-nine patients with de novo stage IV breast cancer diagnosed from 2004 to 2013 were identified. Kaplan-Meier estimate method was fitted to measure overall survival and breast cancer-specific survival (BCSS). Cox proportional hazard analysis was used to evaluate the association between N stage and BCSS after controlling variables such as other patient/tumor characteristics.<h4>Results</h4>The primary site of M1 tumors was mainly upper-outer quadrant and overlapping lesion of the breast. Patients with N1 disease had better overall survival and BCSS than did those without lymph node metastasis. The overall survival and BCSS of M1 patients with N3 disease were significantly lower than that of those with N0, N1 and N2 disease, whereas patients with N2 and N0/N1 involvement showed no significant difference with survival. Multivariate analysis showed that lymph node metastasis was an important prognostic factor for M1 patients (N1 versus N0, hazard ratio [HR] = 0.902, 95% confidence interval [CI]: 0.825-0.986, p = 0.023; N3 versus N0, HR = 1.161, 95% CI: 1.055-1.276, p = 0.002). For M1 patients, age, race, marital status, primary site, ER, PR and HER2 were the independent prognostic factors.<h4>Conclusions</h4>The cohort study provides an insight into de novo stage IV breast cancer with lymph node metastasis. Our results indicated that accurate lymph node evaluation for stage IV patients is still necessary to obtain important prognostic information.
format Article
id doaj-art-413d91c5eb8d493eaf56be53b7eda1af
institution DOAJ
issn 1932-6203
language English
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-413d91c5eb8d493eaf56be53b7eda1af2025-08-20T02:46:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018295310.1371/journal.pone.0182953Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.Chuangang TangPei WangXiaoxin LiBingqing ZhaoHaochang YangHaifeng YuChangwen Li<h4>Background</h4>The objective of this retrospective study was to determine whether lymph node metastasis has a prognostic impact on patients with stage IV breast cancer.<h4>Patients and methods</h4>Seven thousand three hundred and seventy-nine patients with de novo stage IV breast cancer diagnosed from 2004 to 2013 were identified. Kaplan-Meier estimate method was fitted to measure overall survival and breast cancer-specific survival (BCSS). Cox proportional hazard analysis was used to evaluate the association between N stage and BCSS after controlling variables such as other patient/tumor characteristics.<h4>Results</h4>The primary site of M1 tumors was mainly upper-outer quadrant and overlapping lesion of the breast. Patients with N1 disease had better overall survival and BCSS than did those without lymph node metastasis. The overall survival and BCSS of M1 patients with N3 disease were significantly lower than that of those with N0, N1 and N2 disease, whereas patients with N2 and N0/N1 involvement showed no significant difference with survival. Multivariate analysis showed that lymph node metastasis was an important prognostic factor for M1 patients (N1 versus N0, hazard ratio [HR] = 0.902, 95% confidence interval [CI]: 0.825-0.986, p = 0.023; N3 versus N0, HR = 1.161, 95% CI: 1.055-1.276, p = 0.002). For M1 patients, age, race, marital status, primary site, ER, PR and HER2 were the independent prognostic factors.<h4>Conclusions</h4>The cohort study provides an insight into de novo stage IV breast cancer with lymph node metastasis. Our results indicated that accurate lymph node evaluation for stage IV patients is still necessary to obtain important prognostic information.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182953&type=printable
spellingShingle Chuangang Tang
Pei Wang
Xiaoxin Li
Bingqing Zhao
Haochang Yang
Haifeng Yu
Changwen Li
Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
PLoS ONE
title Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
title_full Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
title_fullStr Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
title_full_unstemmed Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
title_short Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
title_sort lymph node status have a prognostic impact in breast cancer patients with distant metastasis
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182953&type=printable
work_keys_str_mv AT chuangangtang lymphnodestatushaveaprognosticimpactinbreastcancerpatientswithdistantmetastasis
AT peiwang lymphnodestatushaveaprognosticimpactinbreastcancerpatientswithdistantmetastasis
AT xiaoxinli lymphnodestatushaveaprognosticimpactinbreastcancerpatientswithdistantmetastasis
AT bingqingzhao lymphnodestatushaveaprognosticimpactinbreastcancerpatientswithdistantmetastasis
AT haochangyang lymphnodestatushaveaprognosticimpactinbreastcancerpatientswithdistantmetastasis
AT haifengyu lymphnodestatushaveaprognosticimpactinbreastcancerpatientswithdistantmetastasis
AT changwenli lymphnodestatushaveaprognosticimpactinbreastcancerpatientswithdistantmetastasis